These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 23303857)

  • 21. Clinical spectrum of mitochondrial DNA depletion due to mutations in the thymidine kinase 2 gene.
    Oskoui M; Davidzon G; Pascual J; Erazo R; Gurgel-Giannetti J; Krishna S; Bonilla E; De Vivo DC; Shanske S; DiMauro S
    Arch Neurol; 2006 Aug; 63(8):1122-6. PubMed ID: 16908738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deoxyribonucleoside kinases in mitochondrial DNA depletion.
    Saada-Reisch A
    Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1205-15. PubMed ID: 15571232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mitochondrial myopathy of childhood associated with mitochondrial DNA depletion and a homozygous mutation (T77M) in the TK2 gene.
    Mancuso M; Filosto M; Bonilla E; Hirano M; Shanske S; Vu TH; DiMauro S
    Arch Neurol; 2003 Jul; 60(7):1007-9. PubMed ID: 12873860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered gene transcription profiles in fibroblasts harboring either TK2 or DGUOK mutations indicate compensatory mechanisms.
    Villarroya J; de Bolós C; Meseguer A; Hirano M; Vilà MR
    Exp Cell Res; 2009 May; 315(8):1429-38. PubMed ID: 19265691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advances in Thymidine Kinase 2 Deficiency: Clinical Aspects, Translational Progress, and Emerging Therapies.
    Berardo A; Domínguez-González C; Engelstad K; Hirano M
    J Neuromuscul Dis; 2022; 9(2):225-235. PubMed ID: 35094997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reversion of mtDNA depletion in a patient with TK2 deficiency.
    Vilà MR; Segovia-Silvestre T; Gámez J; Marina A; Naini AB; Meseguer A; Lombès A; Bonilla E; DiMauro S; Hirano M; Andreu AL
    Neurology; 2003 Apr; 60(7):1203-5. PubMed ID: 12682338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of thymidine kinase 2 alters neuronal bioenergetics and leads to neurodegeneration.
    Bartesaghi S; Betts-Henderson J; Cain K; Dinsdale D; Zhou X; Karlsson A; Salomoni P; Nicotera P
    Hum Mol Genet; 2010 May; 19(9):1669-77. PubMed ID: 20123860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [TK2 mutations and late onset myopathy: first description in a Mexican patient].
    Castro-Macias JI; Quijas-Aldana I; Diaz-Campos MO; Santos-Vazquez G; Normendez-Martinez M; San-Juan D; Anschel DJ
    Rev Neurol; 2018 Sep; 67(6):232. PubMed ID: 30183064
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kinetic properties of mutant human thymidine kinase 2 suggest a mechanism for mitochondrial DNA depletion myopathy.
    Wang L; Saada A; Eriksson S
    J Biol Chem; 2003 Feb; 278(9):6963-8. PubMed ID: 12493767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted impairment of thymidine kinase 2 expression in cells induces mitochondrial DNA depletion and reveals molecular mechanisms of compensation of mitochondrial respiratory activity.
    Villarroya J; Lara MC; Dorado B; Garrido M; García-Arumí E; Meseguer A; Hirano M; Vilà MR
    Biochem Biophys Res Commun; 2011 Apr; 407(2):333-8. PubMed ID: 21382338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thymidine kinase 2 enzyme kinetics elucidate the mechanism of thymidine-induced mitochondrial DNA depletion.
    Sun R; Wang L
    Biochemistry; 2014 Oct; 53(39):6142-50. PubMed ID: 25215937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Depletion of the other genome-mitochondrial DNA depletion syndromes in humans.
    Elpeleg O; Mandel H; Saada A
    J Mol Med (Berl); 2002 Jul; 80(7):389-96. PubMed ID: 12110944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synergistic Deoxynucleoside and Gene Therapies for Thymidine Kinase 2 Deficiency.
    Lopez-Gomez C; Sanchez-Quintero MJ; Lee EJ; Kleiner G; Tadesse S; Xie J; Akman HO; Gao G; Hirano M
    Ann Neurol; 2021 Oct; 90(4):640-652. PubMed ID: 34338329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hearing loss in a patient with the myopathic form of mitochondrial DNA depletion syndrome and a novel mutation in the TK2 gene.
    Martí R; Nascimento A; Colomer J; Lara MC; López-Gallardo E; Ruiz-Pesini E; Montoya J; Andreu AL; Briones P; Pineda M
    Pediatr Res; 2010 Aug; 68(2):151-4. PubMed ID: 20421844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel mutations in the TK2 gene associated with fatal mitochondrial DNA depletion myopathy.
    Blakely E; He L; Gardner JL; Hudson G; Walter J; Hughes I; Turnbull DM; Taylor RW
    Neuromuscul Disord; 2008 Jul; 18(7):557-60. PubMed ID: 18508266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thymidine kinase 2 deficiency-induced mtDNA depletion in mouse liver leads to defect β-oxidation.
    Zhou X; Kannisto K; Curbo S; von Döbeln U; Hultenby K; Isetun S; Gåfvels M; Karlsson A
    PLoS One; 2013; 8(3):e58843. PubMed ID: 23505564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New mutations in TK2 gene associated with mitochondrial DNA depletion.
    Galbiati S; Bordoni A; Papadimitriou D; Toscano A; Rodolico C; Katsarou E; Sciacco M; Garufi A; Prelle A; Aguennouz M'; Bonsignore M; Crimi M; Martinuzzi A; Bresolin N; Papadimitriou A; Comi GP
    Pediatr Neurol; 2006 Mar; 34(3):177-85. PubMed ID: 16504786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion myopathy.
    Saada A; Shaag A; Mandel H; Nevo Y; Eriksson S; Elpeleg O
    Nat Genet; 2001 Nov; 29(3):342-4. PubMed ID: 11687801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thymidine kinase 2 (H126N) knockin mice show the essential role of balanced deoxynucleotide pools for mitochondrial DNA maintenance.
    Akman HO; Dorado B; López LC; García-Cazorla A; Vilà MR; Tanabe LM; Dauer WT; Bonilla E; Tanji K; Hirano M
    Hum Mol Genet; 2008 Aug; 17(16):2433-40. PubMed ID: 18467430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent advances in thymidine kinase 2 (TK2) inhibitors and new perspectives for potential applications.
    Priego EM; Karlsson A; Gago F; Camarasa MJ; Balzarini J; Pérez-Pérez MJ
    Curr Pharm Des; 2012; 18(20):2981-94. PubMed ID: 22571666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.